NDC 51079-812-01 - Nadolol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-812
- Requested NDC
- 51079-812-01
- Package NDCs from labels
- 51079-812-01, 51079-812-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2021-12-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nadolol - Mylan Institutional Inc. | Mylan Institutional Inc. | 2021-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-812-01 | EA - Each | 51079-812 | cc797a32-dd5b-490b-b49d-89c91bba6896 | 1 | 2012-07-24 |
| 51079-812-20 | EA - Each | 51079-812 | 2e94e49d-b2a6-4b51-a906-8bdf99cfc184 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NADOLOL | ACTIVE INGREDIENT | FEN504330V | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| NADOLOL | ACTIVE MOIETY | FEN504330V | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | NADOLOL TABLET [MYLAN INSTITUTIONAL INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nadolol | NADOLOL | BluePoint Laboratories | f11553f1-18ec-41b0-a7ad-1c9f21ef2c9f | 2026-09-07 | Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | American Health Packaging | 9acc0c81-4145-43cc-b31a-7b1e3313259d | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | A-S Medication Solutions | 4580b85b-437c-4c52-bf31-5976968ecd5c | 2026-06-19 | Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | Bryant Ranch Prepack | c154d99c-e4fb-41d0-8fac-e1982672e8d7 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | REMEDYREPACK INC. | 8a224f90-24a5-411e-ac26-6496a1930f3a | 2026-05-18 | Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | Amneal Pharmaceuticals NY LLC | e2e24b14-0169-4028-828a-894ad3c2ba55 | 2026-05-12 | Warnings, Adverse reactions | FEN504330V |
| NADOLOL | NADOLOL | Bryant Ranch Prepack | 64a788d0-b7f0-4f39-8adb-ab68870ecfa5 | 2026-04-29 | Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 2d126308-c58d-4950-9dcb-eaadb1a2054f | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | Golden State Medical Supply, Inc. | 33dcfdb9-1741-71e1-e063-6294a90afdff | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5a8014fb-9b65-4457-bfd5-0ab7e6de330e | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| Nadolol | NADOLOL | American Health Packaging | 9e8e129d-cb17-45fc-b3e2-2600c0166463 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Nadolol | NADOLOL | BluePoint Laboratories | 15822faf-6924-4a63-a4e1-6058b308708c | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Nadolol | NADOLOL | Zydus Lifesciences Limited | 29433c5a-51c6-4fb9-9174-1b1c616c9e57 | 2024-12-05 | FEN504330V | |
| Nadolol | NADOLOL | Bryant Ranch Prepack | 0d66548a-231e-4104-be0c-c6ce1586b46c | 2024-10-02 | Warnings, Adverse reactions | FEN504330V |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Nadolol | NADOLOL | BluePoint Laboratories | 0a2acdc0-aab6-462e-a377-67a0f3d55ec6 | 2024-05-28 | Boxed warning, Warnings, Adverse reactions | FEN504330V |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 368GB5141J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.